Four prominent billionaire investors with differing investment philosophies share one thing in common: their desire to buy more shares of this top-tier company.
Steven Cohen (Trades, Portfolio)'s investment firm, Point72 Asset Management, has recently expanded its investment portfolio by adding shares of Caribou Biosciences Inc (NASDAQ:CRBU). On February 22, 2024, the firm acquired 4,432,602 shares of the biopharmaceutical company, reflecting a significant commitment to the healthcare sector.
Among Microsoft, Apple, Nvidia, Alphabet, Amazon, Meta Platforms, and Tesla, three industry leaders are getting the heave-ho from prominent billionaires, and one is getting eagerly scooped up.
Some prominent billionaire investors have left as much as $390 million on the table by selling out of select high-flying artificial intelligence (AI) stocks ahead of the early-year rally.